Dr. Carla Prado, Associate Professor, 4-002 Li Ka Shing Centre for Health Research Innovation (Office 2-021E), Edmonton, Alberta, Canada T6G 2E1, Tel: 780.492.7934 email:
J Nutr Health Aging. 2020;24(7):783-790. doi: 10.1007/s12603-020-1427-z.
Sarcopenia is a debilitating condition affecting millions of individuals worldwide and is defined with different criteria. The objective of this study was to determine the prevalence of sarcopenia in older Canadians using three internationally accepted criteria.
Observational cohort study.
Data from 12,592 subjects [6,314 males (50.1%), 6,278 females (49.9%)] ≥65 years old in the Canadian Longitudinal Study on Aging were included.
Appendicular lean mass (ALM; kg) and appendicular lean mass index (ALM kg/height in m2) were collected from dual X-ray absorptiometry measurements. Physical performance was assessed using the 4-m gait speed test, and muscle strength was measured by hand dynamometry. Sarcopenia was defined according to criteria put forth by the International Working Group on Sarcopenia (IWGS), Foundation for the National Institutes of Health (FNIH) Sarcopenia Project, and revised European Working Group on Sarcopenia in Older People (EWGSOP). Positive and negative percent agreements and Cohen's kappa (κ) described the agreement among sarcopenia definitions.
Among the evaluated criteria, gait speed ≤ 1.0 m/s (IWGS definition of slowness) was the most frequently identified deficit (56.8% males, 57.2% females). The prevalence of sarcopenia ranged from 1.4 to 5.2% in males and 1.6 to 7.2 % in females among the different definitions. Positive percent agreement values among criteria were generally low (range: 1.5 - 55.3%) and corresponded to κ indicating none to minimal agreement (0.01 - 0.23). Negative percent agreement values were ≥ 95%.
Sarcopenia prevalence was relatively low in older Canadian adults and current definitions had poor agreement in diagnosing individuals as sarcopenic.
肌少症是一种影响全球数百万人的衰弱性疾病,其定义有不同的标准。本研究的目的是使用三种国际公认的标准来确定加拿大老年人中肌少症的患病率。
观察性队列研究。
纳入了加拿大老龄化纵向研究中 12592 名年龄≥65 岁的受试者的数据[男性 6314 名(50.1%),女性 6278 名(49.9%)]。
使用双能 X 线吸收法测量四肢瘦体重(ALM;kg)和四肢瘦体重指数(ALM kg/身高 m2)。使用 4 米步行速度测试评估身体机能,使用握力计测量肌肉力量。肌少症根据国际肌少症工作组(IWGS)、美国国立卫生研究院基金会肌少症计划(FNIH)和修订的欧洲老年人肌少症工作组(EWGSOP)的标准定义。阳性和阴性百分比一致性以及 Cohen's kappa(κ)描述了不同肌少症定义之间的一致性。
在所评估的标准中,步行速度≤1.0 m/s(IWGS 定义的缓慢)是最常见的缺陷(男性 56.8%,女性 57.2%)。不同定义中男性肌少症的患病率为 1.4%至 5.2%,女性为 1.6%至 7.2%。标准之间的阳性百分比一致性值通常较低(范围:1.5%至 55.3%),对应的κ值表明一致性为零至轻度(0.01 至 0.23)。阴性百分比一致性值≥95%。
加拿大老年成年人中肌少症的患病率相对较低,目前的定义在诊断个体为肌少症方面一致性较差。